SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
COVID-19: WHERE ARE WE NOW?
- Sort by:
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
5 of
5
|
SESSION OVERVIEW - COVID-19: WHERE ARE WE NOW?
Irini Sereti
National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States
Brenda E. Crabtree-Ramirez
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
FUTURE DIRECTIONS IN OUTPATIENT THERAPY FOR MILD TO MODERATE COVID-19 (ABSTRACT
31)
Kara W. Chew
University of California Los Angeles, Los Angeles, CA, United States
VIRAL REBOUND DURING AND AFTER SARS-CoV-2 TREATMENT (ABSTRACT
32)
Jonathan Z. Li
Harvard Medical School, Cambridge, MA, United States
WHAT WE KNOW NOW ABOUT LONG COVID SYNDROMES (ABSTRACT
33)
Michael J. Peluso
University of California San Francisco, San Francisco, CA, United States
DISCUSSION WITH ANSWERS TO AUDIENCE QUESTIONS
Irini Sereti
National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States
Brenda E. Crabtree-Ramirez
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
pages: 1
|
presentations:
1 to
5 of
5
|